Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis

Digestive and Liver Disease

Volumn 33, Issue 9, 2001, Pages 768-777

  Susca, M ^a   Grassi, A ^a   Zauli, D ^a   Volta, U ^a   Lenzi, M ^a   Marchesini, G ^a   Bianchi, F B ^a   Ballardini, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Neutrophils; Steatohepatitis; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; CD8 ANTIGEN; COLLAGEN TYPE 3; IMMUNOGLOBULIN; TENASCIN; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL REGENERATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FATTY LIVER; FEMALE; GENDER; GRANULOCYTE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOLOGY; INFLAMMATORY CELL; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER NECROSIS; LYMPHOCYTE COUNT; MALE; OBESITY; POLYMORPHONUCLEAR CELL; STELLATE CELL; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035695238     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(01)80694-0     Document Type: Article

References (36)

1. Review nonalcoholic steatohepatitis
2. Prognosis in nonalcoholic steatohepatitis
3. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis
4. Nonalcoholic steatohepatitis: A study of 49 patients
5. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis
6. Nonalcoholic steatohepatitis: An expanded clinical entity
7. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
8. Nonalcoholic steatohepatitis
9. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
10. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
11. Recurrence of nonalcoholic steatohepatitis following liver transplantation
12. Nonalcoholic steatohepatitis
13. Hepatic dysfunction during hyperalimentation
14. Total parenteral nutrition
15. Association of non-alcoholic fatty liver disease to insulin resistance
16. A possible beneficial effect of metronidazolein reducing TPN-associated liver function derangement
17. Cytokines in alcoholic and nonalcoholic steatohepatitis
18. Hepatobiliary effects of obesity and weight reducing surgery
19. IL-8 induces neutrophil chemotaxis predominantly via type 1 IL-8 receptors
20. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
21. Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
22. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
23. The natural history of nonalcoholic fatty live: A follow-up study
24. Nonalcoholic steatohepatitis and cirrhosis with Mallory's hyalin with ultrastructural study of one case
25. Hepatitis C virus does not cause nonalcoholic steatohepatitis
26. Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler
27. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
28. Diagnosis and interpretation of steatosis and steatohepatitis
29. Non-alcoholic steatohepatitis: Another disease of affluence
30. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis
31. Bile duct cell apoptosis is a rare event in primary biliary cirrhosis
32. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study
33. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis
34. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism
35. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
36. Clinical implications of GBV-C/HGV infection in patients with "HCV related" chronic hepatitis